Press release
Accelerating Precision Medicine: Automated Biobanking Market to Surpass USD 3.12 Billion by 2034
Accelerating Precision Medicine: Automated Biobanking Market
Market Overview: Strong Growth Backed by Technology and Healthcare Demand
According to Exactitude Consultancy, the global automated biobanking market was valued at USD 1.02 billion in 2024 and is poised to reach USD 3.12 billion by 2034, growing at a CAGR of 11.9% during the forecast period (2024-2034).
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/58897
Key Market Highlights:
• Market Size (2024): USD 1.02 billion
• Forecasted Market Size (2034): USD 3.12 billion
• CAGR (2024-2034): 11.9%
• Top Drivers: Rising genomic studies, personalized medicine, chronic disease research, technological automation, government funding
• Key Challenges: High capital investment, data privacy concerns, complex sample interoperability
• Major Players: Hamilton Company, Tecan Group Ltd., Brooks Life Sciences, Thermo Fisher Scientific Inc., ASKION GmbH, LVL Technologies GmbH & Co. KG, Greiner Bio-One International GmbH
Market Segmentation Analysis
By Product:
• Equipment
• Consumables
• Software
• Services
By Application:
• Regenerative Medicine
• Life Science Research
• Clinical Research
By Sample Type:
• Blood Products
• Human Tissue
• Nucleic Acids
• Cell Lines
• Others
By Storage Type:
• Automated Storage
• Manual Storage
By End-User:
• Biobanks
• Hospitals
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
Summary:
The equipment segment-especially automated storage systems and robotic retrieval platforms-holds the largest market share, thanks to its critical role in sample integrity. Blood product biobanks dominate sample type due to widespread use in disease diagnostics. Biopharma and academic research institutes remain dominant end-users, with growing adoption by hospital-based biobanks.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/purchase/?currency=USD&type=single_user_license&report_id=58897
Regional Analysis: Growth Across Geographies
North America:
• Leads the global market due to advanced healthcare infrastructure, NIH-funded biobank initiatives, and major pharmaceutical research.
• U.S. accounts for a major share with high adoption of automated sample storage and management systems.
Europe:
• Strong presence of public-private biobanking collaborations.
• Countries like Germany, the UK, and the Nordics are investing heavily in digital biorepositories.
Asia Pacific:
• Fastest-growing region driven by increasing government funding in countries like China, India, and Japan.
• Rising focus on population genomics and infectious disease surveillance post-COVID.
Latin America:
• Moderate growth with increased academic research collaborations and medical tourism.
Middle East & Africa:
• Nascent stage but gaining traction with investment in genomic research and healthcare digitization.
Regional Summary:
Asia Pacific is expected to witness the highest CAGR (above 13%) during 2024-2034, led by rapid healthcare infrastructure modernization and investments in precision medicine initiatives.
Market Dynamics
Key Growth Drivers:
• Surging demand for personalized medicine: Automated biobanks enable efficient biospecimen storage and faster research turnaround.
• Increasing chronic disease burden: Need for long-term sample preservation for cancer, cardiovascular, and neurological research.
• Rising genomics and proteomics studies: Boosts the need for standardized, scalable, and secure sample storage.
• Technological advancements: Integration of AI, robotics, barcode tracking, and cloud-based LIMS is transforming sample handling.
• Government and private funding: Several national biobanking programs and consortiums are being launched to enhance research.
Challenges:
• High setup costs and maintenance: Robotic storage systems, LIMS, and cryogenic storage require significant investment.
• Data security and privacy: Especially with cross-border research and GDPR-like regulations.
• Interoperability and standardization: Integrating data across institutions and legacy systems remains a hurdle.
Market Trends:
• AI-powered analytics: Emerging trend in biobank data utilization for predictive diagnostics and cohort studies.
• Decentralized and cloud-based biobanks: Especially for global research collaborations.
• Cold-chain automation: Innovations in -80°C or cryogenic robotic storage units.
• Digital twin technology: Biobanks using virtual sample tracking to minimize physical access and errors.
Explore Full Report here: https://exactitudeconsultancy.com/reports/58897/global-automated-biobanking-market
Competitive Landscape: A Race Toward Smart, Scalable Biorepositories
Major Players:
• Hamilton Company - Known for its BiOS automated sample storage systems.
• Tecan Group Ltd. - Offers automation platforms for genomics and life sciences.
• Brooks Life Sciences (Now part of Azenta Life Sciences) - Strong in biorepository services and sample automation.
• Thermo Fisher Scientific Inc. - Comprehensive portfolio including storage, LIMS, and cold-chain solutions.
• ASKION GmbH - Focuses on cryogenic biobank automation.
• Greiner Bio-One - Offers advanced blood sample storage solutions.
• LVL Technologies GmbH - Specializes in barcoded tubes and sample tracking systems.
Summary:
The competitive landscape is moderately consolidated with tier-1 players focusing on modular and AI-integrated platforms. Mergers and acquisitions, collaborations with research institutions, and new product launches remain the dominant strategies.
Conclusion: Unlocking the Potential of Next-Gen Biobanking
The automated biobanking market is on the cusp of a revolution, not only enhancing the speed and precision of sample management but also enabling cross-border biomedical collaboration, rare disease research, and pandemic preparedness.
As personalized medicine and digital health accelerate, investments in smart biorepositories will become foundational to innovation in diagnostics, drug discovery, and population health. With supportive regulations, government initiatives, and expanding applications in regenerative medicine and genomics, the market outlook through 2034 remains highly optimistic.
This report is also available in the following languages : Japanese (自動バイオバンキング), Korean (자동화된 바이오뱅킹), Chinese (自动化生物样本库), French (Biobanque automatisée), German (Automatisiertes Biobanking), and Italian (Biobanking automatizzato), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/58897/global-automated-biobanking-market#request-a-sample
Our More Reports:
Leading-edge Semiconductor Technology Market
https://exactitudeconsultancy.com/reports/66715/leading-edge-semiconductor-technology-market
Trade Wars Impact on Semiconductors Market
https://exactitudeconsultancy.com/reports/66717/trade-wars-impact-on-semiconductors-market
Aircraft Pre-flight Inspection Market
https://exactitudeconsultancy.com/reports/66719/aircraft-pre-flight-inspection-market
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Accelerating Precision Medicine: Automated Biobanking Market to Surpass USD 3.12 Billion by 2034 here
News-ID: 4114465 • Views: …
More Releases from Exactitiude Consultancy
Non-Muscle Invasive Bladder Cancer Market Industry Analysis by Size, Share, Grow …
Introduction
The Non-Muscle Invasive Bladder Cancer (NMIBC) market is poised for significant growth as advancements in intravesical therapies, immuno-oncology drugs, and molecular diagnostics improve patient outcomes. NMIBC, which accounts for about 70-75% of all newly diagnosed bladder cancer cases, is characterized by high recurrence rates but relatively low mortality compared to muscle-invasive forms. The rising global prevalence, particularly among aging populations, is prompting greater investment in early diagnosis, novel drug delivery…
NK Cell Therapy Market Size And Global Industry Forecast 2034
NK Cell Therapy Market Outlook 2024-2034: Immuno-Oncology Innovation and Off-the-Shelf Therapies Set the Stage for Rapid Growth
Introduction
The Natural Killer (NK) Cell Therapy market is one of the most dynamic segments in immuno-oncology, driven by breakthroughs in cell engineering, off-the-shelf allogeneic therapies, and combination regimens with checkpoint inhibitors. NK cells, part of the innate immune system, have demonstrated strong potential in targeting and destroying cancer cells without prior sensitization, making them…
Neuroendocrine Prostate Cancer Market Size, Share and Growth Report, 2034
Introduction
The Neuroendocrine Prostate Cancer (NEPC) market is emerging as a key focus area in oncology due to its aggressive nature, poor prognosis, and increasing recognition as a distinct clinical entity. NEPC can develop de novo or as a treatment-emergent form of advanced prostate cancer following androgen deprivation therapy (ADT) resistance. While rare, NEPC is challenging to treat, requiring a combination of chemotherapy, targeted agents, and investigational therapies. Rising awareness, advancements…
Metastatic Colorectal Cancer Market Size And Global Industry Forecast 2034
Introduction
The Metastatic Colorectal Cancer (mCRC) market is entering a transformative phase as precision medicine, biomarker-driven treatment strategies, and immunotherapy reshape patient care. Increasing adoption of EGFR inhibitors, VEGF inhibitors, immune checkpoint inhibitors, and combination regimens is improving survival rates, while advancements in molecular diagnostics are enabling more tailored treatment approaches. Over the next decade, continuous R&D efforts and expanded access to innovative therapies are expected to drive market growth.
Download Full…
More Releases for Biobanking
Global Biobanking Services & Biobanking Software Market Size, Share, Growth, Tre …
The Biobanking Services Market has witnessed substantial growth in recent years, driven by increasing investments in research and development activities across the healthcare and life sciences sectors. Biobanks play a crucial role in collecting, storing, and managing biological samples, such as blood, tissues, and cells, along with associated clinical and genetic data. This market's size is expected to expand significantly in the coming years due to rising demand for personalized…
Biobanking Market - Strength in Diversity, Defying Disease: Biobanking Fuelling …
Newark, New Castle, USA: The "Biobanking Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Biobanking Market: https://www.growthplusreports.com/report/biobanking-market/7617
This latest report researches the industry structure, sales, revenue, price and…
Mexico Biobanking Market Analysis to 2027
Biobanking Market: Overview
Transparency Market Research (TMR) has published a new report on the biobanking market for the forecast period of 2019-2027. According to the report, the global biobanking market was valued at ~US$ 2 Bn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027.
Biobanking Market: Overview
Growth of the global biobanking market is attributed to an increase in the demand for biobanks in genomics and biomedical research, and rising focus on precision medicine.
North America dominated the…
Biobanking Market Overview and Regional Outlook Study
Biobanking Market Introduction
The term 'biobanking' is often misused to refer to any collection of human biological specimens (biospecimens), regardless of the standards established for various tissue collection procedures or requirements pertaining to ethical and legal considerations. The process of collecting bodily fluids or tissue samples for usage in research to better understand health and disease is referred to as biobanking. Biobank is a sizable collection of biospecimens that are kept…
Biobanking Market: Rising Impressive Business Opportunities Analysis Forecast by …
(Latest Industry Report 2022) Biobanking Market report provides a basic overview of the industry including definitions and classifications. The market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. The study provides a complex examination of the application, including a detailed cost assessment analysis of the products available in the global market with respect to the profit margins of established manufacturers.…
Biobanking Market Industry Trends, Estimation & Forecast, 2017 - 2025
Biobanking is a procedure to collect and preserve biological materials that can be further used for diagnosis, biodiversity studies, and research. The major factors that drive the growth of the global biobanking market include a rise in funding support by private & government organizations.
Furthermore, increased incidence of chronic disease further propel the market growth. However, ethical and legal issues related to biobanking restrict market growth.
The major factors for the…
